Latest:

Fat Pitch Financials

Special situation stocks and value investing

Stock Quote

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Chimerix Inc (NQ: CMRX )

10.28 USD -0.33 (-3.11%)
Official Closing Price Updated: 7:47 PM EST, Mar 3, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 741,000
Open 10.60
Bid (Size) 9.900 (15)
Ask (Size) 10.94 (1)
Prev. Close 10.61
Today's Range 10.05 - 10.89
52wk Range 1.190 - 11.57
Shares Outstanding 47,753,300
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Chimerix to Present at Virtual H.C. Wainwright Global Life Sciences Conference
From GlobeNewswire News Releases
Chimerix, Exclusive Worldwide Licensee of Cantex's Investigational Product, DSTAT, Has Announced Promising Topline Results from the First Cohort of a Randomized COVID-19 Clinical Trial
Cantex Pharmaceuticals, Inc., a clinical stage biopharmaceutical company developing proprietary pharmaceuticals for the treatment of inflammatory lung diseases and cancer, today announced that... 
From PR Newswire

Performance

YTD
+115.97%
+115.97%
1 Month
+15.77%
+15.77%
3 Month
+195.40%
+195.40%
6 Month
+283.58%
+283.58%
1 Year
+497.67%
+497.67%

More News

Read More
Chimerix Reports Promising Topline Results from First Cohort of a Randomized COVID-19 Trial with DSTAT
From GlobeNewswire News Releases
Chimerix Reports Fourth Quarter and Year End 2020 Financial Results and Provides Operational Update
From GlobeNewswire News Releases
Chimerix to Report Fourth Quarter and Year End 2020 Financial Results and Provide an Operational Update on February 25, 2021
From GlobeNewswire News Releases
Chimerix Announces Closing of Public Offering of Common Stock and Full Exercise of Option to Purchase Additional Shares
From GlobeNewswire News Releases
Chimerix Announces Pricing of Public Offering of Common Stock
From GlobeNewswire News Releases
Chimerix Announces Proposed $75,000,000 Public Offering of Common Stock
From GlobeNewswire News Releases
Chimerix's DSTAT Shows Promising Results In First Cohort Of COVID-19 Study
Tags General FDA Covid/19
From Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Tags DYNT Benzinga Movers
From Benzinga
Looking For The Best Biotech Stocks To Watch This Week? 3 Up 70%+ Last Week
Tags Market News
From StockMarket.com
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.